Abstract
In systemic diseases, such as connective tissue diseases and metabolic syndromes, involvement of multiple organs is the general rule. Yet cardiac involvement in many systemic diseases is not well recognized, as the dominant manifestations frequently reside in other organ systems. Cardiac involvement is very common with many systemic diseases and may account for serious morbidity or mortality. The early recognition of cardiac involvement may impact upon patient management and prognosis. For instance, in a patient with thalassemia requiring frequent blood transfusions, the detection of myocardial dysfunction due to myocardial iron deposition will lead to intensification of chelation therapy. The major categories of systemic diseases with cardiac involvement are listed in Table 17.1. Instead of providing an encyclopedic description of cardiac manifestations in a wide range of systemic diseases, the approach taken in this chapter is to outline important principles that should be considered in dealing with patients with any systemic disease. The intention is that a good understanding of the unifying principles is likely to be more inclusive of the variable and ever expanding range of cardiac manifestations than any comprehensive listing, and thus more useful to the echocardiographers who evaluate these patients. We do not provide in-depth review of many of the diseases that are mentioned, but instead discuss specific diseases in detail to illustrate the underlying principles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc. 2002;77:139-147.
Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis, and management. Heart. 2004 Oct;90(10):1224-1228.
Pellikka PA, Tajik AJ, Khandheria BK, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188-1196.
Callahan JA, Wroblewski EM, Reeder GS, Edwards WD, Seward JB, Tajik AJ. Echocardiographic features of carcinoid heart disease. Am J Cardiol. 1982 Oct;50(4):762-768.
Chan KL, Callahan JA, Seward JB, Tajik AJ, Gordon H. Marfan syndrome diagnosed in patients 32 years of age or older. Mayo Clin Proc. 1987 Jul;62(7):589-594.
Dean JCS. Management of Marfan syndrome. Heart. 2002 Jul;88(1):97-103.
Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Annals Thoracic Surg. 2002 Feb;73(2):438-443.
von Kodolitsch Y, Robinson PN. Marfan syndrome: an update of genetics, medical and surgical management. Heart. 2007;93(6):755-760.
Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118(25):2754-2762.
Nef HM, Mollmann H, Elsasser A. Tako-tsubo cardiomyopathy (apical ballooning). Heart. 2007;93(10):1309-1315.
Butany J, Bahl NE, Morales K, et al. The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature. Cardiovasc Pathol. 2006;15(4):222-227.
Roberts WC, McAllister HA Jr, Ferrans V. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (Group I) and review of 78 previously described necropsy patients (Group II). Am J Med. 1977;63:86-108.
Little WC, Freeman GL. Pericardial disease. Circulation. 2006 Mar 28;113(12):1622-1632.
Cervera R, Font J, Parë C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis. 1992;51:156-159.
Cujec B, Sibley J, Haga M. Cardiac abnormalities in patients with systemic lupus erythematosus. Can J Cardiol. 1991;7:343-349.
Albat B, Missov E, Leclercq F, Grolleau R, Thevenet A. Adult coronary aneurysms related to Kawasaki disease. J Cardiovasc Surg. 1994;35:57-60.
Landing BH, Larson EJ. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol. 1987;1:218-229.
Virmani R, Burke A. Pathological features of aortitis. Cardiovasc Pathol. 1994;3:205-216.
Lantuejoul S, Barbour A, Brambilla E, Nicholson AG, Sheppard MN. Idiopathic and non-idiopathic giant cell aortitis: a clinicopathological study of 43 cases. Mod Pathol. 2007;20:59A.
Graor RA. Takayasu’s Disease. Curr Probl Cardiol. 1990;5:679-682.
Sharma BK, Jain S, Radotra BD. An autopsy study of Takayasu arteritis in India. Int J Cardiol. 1998 Oct 1;66(Suppl):85-90.
Benditt DG, Dunnigan A, Milstein S, Limas C. Coexistence of skeletal muscle abnormalities in cardiomyopathy. J Am Coll Cardiol. 1989 Nov 15;14(6):1474-1475.
Posada RI, Gutierrez-Rivas E, Cabello A. [Cardiac involvement in neuromuscular diseases]. Rev Esp Cardiol. 1997 Dec;50(12):882-901.
Kinoshita H, Goto Y, Ishikawa M, et al. A carrier of Duchenne muscular dystrophy with dilated cardiomyopathy but no skeletal muscle symptom. Brain Dev. 1995 May;17(3):202-205.
Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000 Feb 8;101(5):473-476.
Anastasakis A, Karandreas N, Stathis P, et al. Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics. Int J Cardiol. 2003 Jun;89(2–3):249-256.
Isnard R, Kalotka H, Durr A, et al. Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich’s ataxia. Circulation. 1997;95(9):2247-2249.
Boyer SH, Chisholm AW, McKusick VA. Cardiac aspects of Friedreich’s ataxia. Circulation. 1962 Mar;25:493-505.
Osterziel KJ, Bit-Avragim N, Bunse M. Cardiac hypertrophy in Friedreich’s ataxia. Cardiovasc Res. 2002 Jun;54(3):694-696.
Alboliras ET, Shub C, Gomez MR, et al. Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol. 1986 Sep 1;58(6):518-524.
Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA. Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol. 1986 Jun;7(6):1370-1378.
Cueto-Garcia L, Reeder GS, Kyle RA, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. JACC. 1985;6:737-743.
Walley VM, Kisilevsky R, Young ID. Amyloid and the cardiovascular system: a review of pathogenesis and pathology with clinical correlations. Cardiovas Pathol. 1995;4:79-102.
Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005;112(13):2047-2060.
Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1990;16:1135-1141.
Klein AL, Tajik AJ. Doppler assessment of diastolic function in cardiac amyloidosis. Echocardiography. 1991;8:233-251.
Hyett J, Moscoso G, Nicolaides K. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997;69(2):207–16.
Marino B, Digilio MC. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol. 2000 Nov;9(6):303-315.
Tennstedt C, Chaoui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart. 1999 Jul;82(1):34-39.
Richards AA, Santos LJ, Nichols HA, et al. Cryptic chromosomal abnormalities identified in children with congenital heart disease. Pediatr Res. 2008 Oct;64(4):358-363.
Song MS, Hu A, Dyhamenahali U, et al. Extracardiac lesions and chromosomal abnormalities associated with major fetal heart defects: comparison of intrauterine, postnatal and postmortem diagnoses. Ultrasound Obstet Gynecol. 2009 May;33(5):552-559.
Schwanitz G, Zerres K, Gembruch U, Bald R, Gamerdinger F, Hansmann M. Prenatal detection of heart defects as an indication for chromosome analysis. Ann Genet. 1990;33(2):79-83.
Digilio MC, Marino B, Giannotti A, Novelli G, Dallapiccola B. Conotruncal heart defects and chromosome 22q11 microdeletion. J Pediatr. 1997 Apr;130(4):675-677.
Johnson MC, Hing A, Wood MK, Watson MS. Chromosome abnormalities in congenital heart disease. Am J Med Genet. 1997 Jun 13;70(3):292-298.
Sreeram N, Wren C, Bhate M, Robertson P, Hunter S. Cardiac abnormalities in the fragile X syndrome. Br Heart J. 1989 Mar;61(3):289-291.
Mandell BF, Hoffman GS. Rheumatic diseases and the cardiovascular system. In Baknwald E, Zipes DP, Libby P ed. Heart disease-a text book of cardiovascular medicine. 6th ed. Saunders 2001:2199-2210.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Chan, KL., Veinot, J.P. (2010). Cardiac Involvement by Systemic Diseases. In: Anatomic Basis of Echocardiographic Diagnosis. Springer, London. https://doi.org/10.1007/978-1-84996-387-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-84996-387-9_17
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-386-2
Online ISBN: 978-1-84996-387-9
eBook Packages: MedicineMedicine (R0)